Susquehanna International Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-38,545
| Closed | -$189K | – | 6809 |
|
|
2021
Q3 | $189K | Buy |
+38,545
| New | +$189K | ﹤0.01% | 4739 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6207 |
|
|
2021
Q1 | – | Sell |
-13,926
| Closed | -$60K | – | 6027 |
|
|
2020
Q4 | $60K | Buy |
+13,926
| New | +$60K | ﹤0.01% | 4597 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5213 |
|
|
2020
Q2 | – | Sell |
-17,276
| Closed | -$50K | – | 5249 |
|
|
2020
Q1 | $50K | Sell |
17,276
-45,947
| -73% | -$133K | ﹤0.01% | 4215 |
|
|
2019
Q4 | $240K | Buy |
63,223
+2,405
| +4% | +$9.13K | ﹤0.01% | 3339 |
|
|
2019
Q3 | $311K | Sell |
60,818
-38,177
| -39% | -$195K | ﹤0.01% | 3373 |
|
|
2019
Q2 | $614K | Buy |
98,995
+34,643
| +54% | +$215K | ﹤0.01% | 2697 |
|
|
2019
Q1 | $458K | Buy |
64,352
+16,693
| +35% | +$119K | ﹤0.01% | 1920 |
|
|
2018
Q4 | $407K | Buy |
+47,659
| New | +$407K | ﹤0.01% | 2309 |
|
|
2018
Q3 | – | Sell |
-11,876
| Closed | -$307K | – | 5113 |
|
|
2018
Q2 | $307K | Buy |
+11,876
| New | +$307K | ﹤0.01% | 2684 |
|
|
2018
Q1 | – | Sell |
-134,465
| Closed | -$4.56M | – | 4888 |
|
|
2017
Q4 | $4.56M | Sell |
134,465
-76,395
| -36% | -$2.59M | ﹤0.01% | 611 |
|
|
2017
Q3 | $4.46M | Buy |
210,860
+184,388
| +697% | +$3.9M | ﹤0.01% | 569 |
|
|
2017
Q2 | $463K | Buy |
+26,472
| New | +$463K | ﹤0.01% | 2451 |
|
|
2017
Q1 | – | Sell |
-29,028
| Closed | -$491K | – | 4748 |
|
|
2016
Q4 | $491K | Buy |
+29,028
| New | +$491K | ﹤0.01% | 2992 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4254 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4345 |
|
|
2016
Q1 | – | Sell |
-8,322
| Closed | -$236K | – | 4586 |
|
|
2015
Q4 | $236K | Buy |
+8,322
| New | +$236K | ﹤0.01% | 3620 |
|